How much does invega cost?

Invega Price and Affordability

The cost of Invega (paliperidone) can vary depending on the dosage, form (tablet or injectable), and location. Invega is a prescription medication used to treat schizophrenia and schizoaffective disorder.

Typical Costs

According to the manufacturer, Janssen Pharmaceuticals, the wholesale acquisition cost (WAC) of Invega in the United States is around $800 to $1,000 per month for a 3mg dose [1]. However, actual costs can differ widely depending on insurance coverage, pharmacy discounts, and other factors.

Insurance Coverage and Discounts

Many insurance plans cover Invega, including Medicare and Medicaid. Patients may be eligible for copay cards, patient assistance programs, or manufacturer discounts to reduce their out-of-pocket costs [2].

Generic or Biosimilar Options

There are no approved generic or biosimilar versions of Invega in the United States. However, several generic paliperidone products have been approved for marketing in other countries. If a generic or biosimilar option becomes available in the US, it could potentially reduce costs [3].

Clinical Trials and Off-Label Use

Invega has been studied in various clinical trials, including those examining its effectiveness in treating schizoaffective disorder and off-label uses such as bipolar disorder. While these trials may provide valuable insights, they do not directly influence pricing [4].

Patent Expiration

Invega's patent will expire in 2026, which could lead to the introduction of generic or biosimilar products and potential price competition [5].

Sources

[1] Janssen Pharmaceuticals. (n.d.). Invega (paliperidone) tablets. Retrieved from https://www.invega.com

[2] Invega Patient Assistance Program. (n.d.). Retrieved from https://www.invega.com/patient-assistance-program

[3] DrugPatentWatch.com. (n.d.). Paliperidone. Retrieved from https://www.drugpatentwatch.com/drug/paliperidone

[4] ClinicalTrials.gov. (n.d.). Paliperidone Clinical Trials. Retrieved from https://clinicaltrials.gov/ct2/results?term=paliperidone

[5] Janssen Pharmaceuticals. (n.d.). Invega (paliperidone) injectable. Retrieved from https://www.invega.com/injectable

Sources Cited

1. Janssen Pharmaceuticals
2. Invega Patient Assistance Program
3. DrugPatentWatch.com
4. ClinicalTrials.gov
5. Janssen Pharmaceuticals